GlassScriptPhysician profile
Eryn Broshar
NPI 1548009855
$515.64
in general payments reported to CMS, 2019-2025
7 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $215 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $174.80 | 2024-2025 | Vaxneuvance, Vaxelis, Enflonsia |
| Corium, LLC | $117.15 | 2024-2025 | Azstarys |
| Seqirus USA INC | $57.90 | 2025 | Flucelvax |
| Cumberland Pharmaceuticals, INC. | $52.63 | 2024 | Kristalose |
| Glaxosmithkline, LLC. | $50.93 | 2025 | Penmenvy, Bexsero |
| Sanofi-Aventis U.S. LLC | $46.88 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $15.35 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eryn Broshar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.